{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:38:58Z","timestamp":1762504738311},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Somatostatin receptors have been found on a variety of neuroendocrine tumours, such as carcinoids and paragangliomas, as well as on most pancreatic endocrine and breast tumours. Somatostatin receptor scintigraphy with a radionuclide-labelled somatostatin analogue, [111Indium-diethylenetriaminopenta-acetic acid]octreotide, is a sensitive and specific technique for visualizing in vivo the presence of somatostatin receptors on various tumours.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Material was identified from previous review articles, references cited in original papers and a Medline search of the literature. Additional material was obtained from recently published abstracts of meetings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results and conclusion<\/jats:title>\n                  <jats:p>Somatostatin receptor imaging of neuroendocrine tumours is essential in the diagnostic evaluation of most of these tumours. The expression of somatostatin receptors in vivo not only predicts the outcome of somatostatin analogue treatment but also opens the possibility of new therapeutic strategies. Because better information about spread of the disease can be obtained, more justifiable options for therapy can be proposed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1046\/j.1365-2168.2001.01644.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:18:48Z","timestamp":1047367128000},"page":"31-40","source":"Crossref","is-referenced-by-count":56,"title":["Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours"],"prefix":"10.1093","volume":"88","author":[{"given":"G D","family":"Slooter","sequence":"first","affiliation":[{"name":"Department of Surgery, Erasmus Medical Centre Rotterdam , Rotterdam,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Mearadji","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus Medical Centre Rotterdam , Rotterdam,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W A P","family":"Breeman","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Erasmus Medical Centre Rotterdam , Rotterdam,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R L","family":"Marquet","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus Medical Centre Rotterdam , Rotterdam,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Erasmus Medical Centre Rotterdam , Rotterdam,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E P","family":"Krenning","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Erasmus Medical Centre Rotterdam , Rotterdam,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Erasmus Medical Centre Rotterdam , Rotterdam,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C H J","family":"van Eijck","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus Medical Centre Rotterdam , Rotterdam,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,1,1]]},"reference":[{"key":"2024093005330796700_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.179.4068.77","article-title":"Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone","volume":"179","author":"Brazeau","year":"1973","journal-title":"Science"},{"key":"2024093005330796700_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/gut.27.4.457","article-title":"Endogenous somatostatin and the gut","volume":"27","author":"Lucey","year":"1986","journal-title":"Gut"},{"key":"2024093005330796700_bib3","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJM198312223092506","article-title":"Somatostatin (second of two parts)","volume":"309","author":"Reichlin","year":"1983","journal-title":"N Engl J Med"},{"key":"2024093005330796700_bib4","first-page":"6977","article-title":"Oncological applications of somatostatin analogues","volume":"48","author":"Schally","year":"1988","journal-title":"Cancer Res"},{"key":"2024093005330796700_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue","volume":"315","author":"Kvols","year":"1986","journal-title":"N Engl J Med"},{"key":"2024093005330796700_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/edrv-12-4-450","article-title":"The role of somatostatin and its analogs in the diagnosis and treatment of tumors","volume":"12","author":"Lamberts","year":"1991","journal-title":"Endocr Rev"},{"key":"2024093005330796700_bib7","first-page":"5969","article-title":"Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas","volume":"50","author":"Reubi","year":"1990","journal-title":"Cancer Res"},{"key":"2024093005330796700_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000180970","article-title":"Somatostatin receptors in normal and tumoral tissue","volume":"29","author":"Reubi","year":"1988","journal-title":"Horm Res"},{"key":"2024093005330796700_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ijc.2910430302","article-title":"Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas","volume":"43","author":"Papotti","year":"1989","journal-title":"Int J Cancer"},{"key":"2024093005330796700_bib10","first-page":"23","article-title":"Functional role of somatostatin receptors in neuroendocrine and immune cells","volume":"31","author":"Hofland","year":"1999","journal-title":"Ann Med"},{"key":"2024093005330796700_bib11","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI117090","article-title":"Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201\u2013995 in treatment of human endocrine tumors","volume":"93","author":"Kubota","year":"1994","journal-title":"J Clin Invest"},{"key":"2024093005330796700_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350317","article-title":"Molecular pharmacology of somatostatin receptor subtypes","volume":"20","author":"Patel","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"2024093005330796700_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jcem.84.2.5497","article-title":"Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors","volume":"84","author":"Hofland","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024093005330796700_bib14","first-page":"2136","article-title":"Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase","volume":"6","author":"Yamada","year":"1992","journal-title":"Mol Endocrinol"},{"key":"2024093005330796700_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0960-0760(92)90184-K","article-title":"Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications","volume":"43","author":"Reubi","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2024093005330796700_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0016-5085(88)80025-8","article-title":"Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas","volume":"95","author":"Reubi","year":"1988","journal-title":"Gastroenterology"},{"key":"2024093005330796700_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(94)92637-9","article-title":"Somatostatin receptor scintigraphy in primary breast cancer","volume":"343","author":"van Eijck","year":"1994","journal-title":"Lancet"},{"key":"2024093005330796700_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<188::AID-CNCR26>3.0.CO;2-3","article-title":"Expression of somatostatin receptors in peritumoral veins of human tumors","volume":"85","author":"Denzler","year":"1999","journal-title":"Cancer"},{"key":"2024093005330796700_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(89)91258-0","article-title":"Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin","volume":"i","author":"Krenning","year":"1989","journal-title":"Lancet"},{"key":"2024093005330796700_bib20","first-page":"1","volume-title":"Nuclear Medicine Annual","author":"Krenning","year":"1995"},{"key":"2024093005330796700_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF01213548","article-title":"The diagnostic utility of somatostatin receptor scintigraphy in oncology","volume":"122","author":"Valkema","year":"1996","journal-title":"J Cancer Res Clin Oncol"},{"key":"2024093005330796700_bib22","first-page":"677","article-title":"Detection of endocrine tumors of the digestive tract. Value and limitations of scintigraphy of somatostatin receptors","volume":"25","author":"Le Guludec","year":"1996","journal-title":"Presse Med"},{"key":"2024093005330796700_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-125-1-199607010-00005","article-title":"Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study","volume":"125","author":"Gibril","year":"1996","journal-title":"Ann Intern Med"},{"key":"2024093005330796700_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0016-5085(96)70052-5","article-title":"Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger\u2013Ellison","volume":"111","author":"Cadiot","year":"1996","journal-title":"Gastroenterology"},{"key":"2024093005330796700_bib25","first-page":"853","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors","volume":"38","author":"Lebtahi","year":"1997","journal-title":"J Nucl Med"},{"key":"2024093005330796700_bib26","first-page":"873","article-title":"Octreotide scintigraphy for the detection of paragangliomas","volume":"34","author":"Kwekkeboom","year":"1993","journal-title":"J Nucl Med"},{"key":"2024093005330796700_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/110241598750004913","article-title":"Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE)","volume":"164","author":"Jalil","year":"1998","journal-title":"Eur J Surg"},{"key":"2024093005330796700_bib28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0969-8051(96)00065-0","article-title":"The role of radiolabeled somatostatin analogs in adrenal imaging","volume":"23","author":"Maurea","year":"1996","journal-title":"Nucl Med Biol"},{"key":"2024093005330796700_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003072-199904000-00008","article-title":"Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid","volume":"24","author":"Krausz","year":"1999","journal-title":"Clin Nucl Med"},{"key":"2024093005330796700_bib30","first-page":"S219","article-title":"Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide","volume":"31","author":"Krenning","year":"1999","journal-title":"Ital J Gastroenterol Hep"},{"key":"2024093005330796700_bib31","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s002590050296","article-title":"Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings","volume":"25","author":"Adams","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"2024093005330796700_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000658-199608000-00002","article-title":"The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors","volume":"224","author":"van Eijck","year":"1996","journal-title":"Ann Surg"},{"key":"2024093005330796700_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/02841868909111217","article-title":"Medical treatment of neuroendocrine gut and pancreatic tumors","volume":"28","author":"Oberg","year":"1989","journal-title":"Acta Oncol"},{"key":"2024093005330796700_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2362.1993.tb00777.x","article-title":"Long-term treatment with octreotide in patients with the Zollinger\u2013Ellison syndrome","volume":"23","author":"Ruszniewski","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"2024093005330796700_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/106002809703100217","article-title":"Octreotide in hyperinsulinism","volume":"31","author":"Barrons","year":"1997","journal-title":"Ann Pharmacother"},{"key":"2024093005330796700_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/jcem-71-3-566","article-title":"Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy","volume":"71","author":"Lamberts","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2024093005330796700_bib37","first-page":"561","article-title":"Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours","volume":"119","author":"Lamberts","year":"1988","journal-title":"Acta Endocrinol"},{"key":"2024093005330796700_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.1989.tb00436.x","article-title":"Resistance of metastatic pancreatic endocrine tumours after long-term treatment with the somatostatin analogue octreotide (SMS 201\u2013995)","volume":"30","author":"Wynick","year":"1989","journal-title":"Clin Endocrinol"},{"key":"2024093005330796700_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/pgmj.72.849.403","article-title":"Somatostatin analogue treatment of neuroendocrine tumours","volume":"72","author":"de Herder","year":"1996","journal-title":"Postgrad Med J"},{"key":"2024093005330796700_bib40","first-page":"12","article-title":"Is somatostatin useful in the treatment of acute pancreatitis? A meta-analysis","volume":"49","author":"Carballo","year":"1991","journal-title":"Digestion"},{"key":"2024093005330796700_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.45.1.97","article-title":"A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis","volume":"45","author":"Uhl","year":"1999","journal-title":"Gut"},{"key":"2024093005330796700_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000051481","article-title":"Role of octreotide and somatostatin in the treatment of intestinal fistulae","volume":"60","author":"Dorta","year":"1999","journal-title":"Digestion"},{"key":"2024093005330796700_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000051489","article-title":"Management of digestive tract fistulas. A Review","volume":"60","author":"Falconi","year":"1999","journal-title":"Digestion"},{"key":"2024093005330796700_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9610(92)90264-R","article-title":"Role of octreotide in the prevention of postoperative complications following pancreatic resection","volume":"163","author":"Buchler","year":"1992","journal-title":"Am J Surg"},{"key":"2024093005330796700_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000051478","article-title":"Somatostatin or octreotide in acute variceal bleeding","volume":"60","author":"Hadengue","year":"1999","journal-title":"Digestion"},{"key":"2024093005330796700_bib46","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(97)05099-X","article-title":"Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial","volume":"350","author":"Avgerinos","year":"1997","journal-title":"Lancet"},{"key":"2024093005330796700_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(93)90009-3","article-title":"Somatostatin analogs for diagnosis and treatment of cancer","volume":"60","author":"Weckbecker","year":"1993","journal-title":"Pharmacol Ther"},{"key":"2024093005330796700_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2362.1994.tb00972.x","article-title":"Somatostatin and the immune and haematopoetic system; a review","volume":"24","author":"van Hagen","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"2024093005330796700_bib49","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ijc.2910560513","article-title":"High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor\u2013host interaction?","volume":"56","author":"Reubi","year":"1994","journal-title":"Int J Cancer"},{"key":"2024093005330796700_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000201388","article-title":"Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo","volume":"57","author":"Weckbecker","year":"1996","journal-title":"Digestion"},{"key":"2024093005330796700_bib51","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1284::AID-CNCR10>3.0.CO;2-P","article-title":"A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma","volume":"85","author":"Ingle","year":"1999","journal-title":"Cancer"},{"key":"2024093005330796700_bib52","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/bjs.1800810925","article-title":"Somatostatin receptor-dependent growth inhibition of liver metastases by octreotide","volume":"81","author":"van Eijck","year":"1994","journal-title":"Br J Surg"},{"key":"2024093005330796700_bib53","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/endo-124-2-1017","article-title":"Direct inhibitory effects of a somatostatin analog, SMS 201\u2013995, on AR4\u20132J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism","volume":"124","author":"Viguerie","year":"1989","journal-title":"Endocrinology"},{"key":"2024093005330796700_bib54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI112780","article-title":"Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin","volume":"79","author":"Chou","year":"1987","journal-title":"J Clin Invest"},{"key":"2024093005330796700_bib55","first-page":"571","article-title":"Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells","volume":"131","author":"Hofland","year":"1992","journal-title":"Endocrinology"},{"key":"2024093005330796700_bib56","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ijc.2910600521","article-title":"Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate","volume":"60","author":"Qin","year":"1995","journal-title":"Int J Cancer"},{"key":"2024093005330796700_bib57","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1073\/pnas.86.6.2003","article-title":"Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase","volume":"86","author":"Liebow","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2024093005330796700_bib58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0026-0495(96)90071-2","article-title":"Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase","volume":"45","author":"Lopez","year":"1996","journal-title":"Metabolism"},{"key":"2024093005330796700_bib59","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0959-8049(92)90060-F","article-title":"Octreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumours","volume":"28A","author":"Tiensuu Janson","year":"1992","journal-title":"Eur J Cancer"},{"key":"2024093005330796700_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00001622-199801000-00010","article-title":"Advances in chemotherapy and biotherapy of endocrine tumors","volume":"10","author":"Oberg","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"2024093005330796700_bib61","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/02841869109092409","article-title":"Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogue octreotide","volume":"30","author":"Oberg","year":"1991","journal-title":"Acta Oncol"},{"key":"2024093005330796700_bib62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF01536042","article-title":"Use of somatostatin analog in management of carcinoid syndrome","volume":"34","author":"Vinik","year":"1989","journal-title":"Dig Dis Sci"},{"issue":"9 Suppl 2","key":"2024093005330796700_bib63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0026-0495(90)90237-7","article-title":"Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase","volume":"39","author":"Liebow","year":"1990","journal-title":"Metabolism"},{"key":"2024093005330796700_bib64","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gut.38.3.430","article-title":"Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours","volume":"38","author":"Arnold","year":"1996","journal-title":"Gut"},{"key":"2024093005330796700_bib65","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1023\/A:1008205415035","article-title":"High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects","volume":"8","author":"Eriksson","year":"1997","journal-title":"Ann Oncol"},{"key":"2024093005330796700_bib66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/02841869709001323","article-title":"Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs","volume":"36","author":"Imam","year":"1997","journal-title":"Acta Oncol"},{"issue":"9 Suppl 2","key":"2024093005330796700_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0026-0495(92)90027-8","article-title":"Gallstones during octreotide therapy","volume":"41","author":"Dowling","year":"1992","journal-title":"Metabolism"},{"key":"2024093005330796700_bib68","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1200\/JCO.1999.17.4.1111","article-title":"Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms","volume":"17","author":"Wymenga","year":"1999","journal-title":"J Clin Oncol"},{"key":"2024093005330796700_bib69","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<830::AID-CNCR20>3.0.CO;2-#","article-title":"Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors","volume":"79","author":"Trendle","year":"1997","journal-title":"Cancer"},{"key":"2024093005330796700_bib70","first-page":"2002","article-title":"Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide","volume":"37","author":"Andersson","year":"1996","journal-title":"J Nucl Med"},{"key":"2024093005330796700_bib71","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00006231-199803000-00013","article-title":"Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy","volume":"19","author":"De Jong","year":"1998","journal-title":"Nucl Med Commun"},{"key":"2024093005330796700_bib72","first-page":"659","article-title":"Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes","volume":"57","author":"Duncan","year":"1997","journal-title":"Cancer Res"},{"key":"2024093005330796700_bib73","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"2024093005330796700_bib74","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1118\/1.596927","article-title":"Radiation spectra for Auger-electron emitting radionuclides: report no. 2 of AAPM Nuclear Medicine Task Group no. 6","volume":"19","author":"Howell","year":"1992","journal-title":"Med Phys"},{"key":"2024093005330796700_bib75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2214\/ajr.160.4.8456649","article-title":"Sosman Lecture. The Auger process: a therapeutic promise?","volume":"160","author":"Adelstein","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"2024093005330796700_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000201387","article-title":"Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer","volume":"57","author":"Stolz","year":"1996","journal-title":"Digestion"},{"key":"2024093005330796700_bib77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19960117)65:2<214::AID-IJC15>3.0.CO;2-D","article-title":"Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analogue","volume":"65","author":"Zamora","year":"1996","journal-title":"Int J Cancer"},{"key":"2024093005330796700_bib78","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s002590050268","article-title":"The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours","volume":"25","author":"Stolz","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"2024093005330796700_bib79","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<767::AID-IJC17>3.0.CO;2-T","article-title":"Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver","volume":"81","author":"Slooter","year":"1999","journal-title":"Int J Cancer"},{"key":"2024093005330796700_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000201398","article-title":"Somatostatin receptor: scintigraphy and radionuclide therapy","volume":"57","author":"Krenning","year":"1996","journal-title":"Digestion"},{"key":"2024093005330796700_bib81","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/bjs.1800820144","article-title":"Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha","volume":"82","author":"Slooter","year":"1995","journal-title":"Br J Surg"},{"key":"2024093005330796700_bib82","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1073\/pnas.95.4.1794","article-title":"Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin","volume":"95","author":"Nagy","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024093005330796700_bib83","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1073\/pnas.93.6.2464","article-title":"High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500\u20131000 times more potent: structure\u2013activity relationship of daunosamine-modified derivatives of doxorubicin","volume":"93","author":"Nagy","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024093005330796700_bib84","first-page":"4132","article-title":"Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses","volume":"58","author":"Koppan","year":"1998","journal-title":"Cancer Res"},{"key":"2024093005330796700_bib85","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<592::AID-IJC20>3.0.CO;2-0","article-title":"Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238","volume":"82","author":"Kahan","year":"1999","journal-title":"Int J Cancer"},{"key":"2024093005330796700_bib86","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/annonc\/10.suppl_2.S23","article-title":"Radiolabelled somatostatin analogue (s) for peptide receptor scintigraphy and radionuclide therapy","volume":"10","author":"Krenning","year":"1999","journal-title":"Ann Oncol"},{"key":"2024093005330796700_bib87","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006231-200001000-00016","article-title":"Toxicity of high-activity 111In-octreotide therapy in patients with disseminated neuroendocrine tumours","volume":"21","author":"Caplin","year":"2000","journal-title":"Nucl Med Commun"},{"key":"2024093005330796700_bib88","first-page":"1519","article-title":"Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome","volume":"37","author":"Fjalling","year":"1996","journal-title":"J Nucl Med"},{"key":"2024093005330796700_bib89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/028418699431465","article-title":"Treatment with high dose [(111) In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors; evaluation of therapeutic and toxic effects","volume":"38","author":"Tiensuu Janson","year":"1999","journal-title":"Acta Oncol"},{"key":"2024093005330796700_bib90","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0001-2998(95)80016-6","article-title":"Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues","volume":"25","author":"Wiseman","year":"1995","journal-title":"Semin Nucl Med"},{"key":"2024093005330796700_bib91","first-page":"94","article-title":"In situ radiotherapy with 111In-pentetreotide: initial observations and future directions","volume":"4","author":"McCarthy","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"2024093005330796700_bib92","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1172\/JCI118618","article-title":"Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells","volume":"97","author":"Rauly","year":"1996","journal-title":"J Clin Invest"},{"key":"2024093005330796700_bib93","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1089\/10430349950018391","article-title":"Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer","volume":"10","author":"Rochaix","year":"1999","journal-title":"Hum Gene Ther"}],"container-title":["Journal of British Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2168.2001.01644.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2168.2001.01644.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/88\/1\/31\/59439203\/bjs420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/88\/1\/31\/59439203\/bjs420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:34:01Z","timestamp":1727674441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/88\/1\/31\/6156361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,1,1]]},"published-print":{"date-parts":[[2001,1,1]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2168.2001.01644.x","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"type":"print","value":"0007-1323"},{"type":"electronic","value":"1365-2168"}],"subject":[],"published-other":{"date-parts":[[2001,1]]},"published":{"date-parts":[[2001,1,1]]}}}